Literature DB >> 24280644

Azelaic acid: Properties and mode of action.

M A Sieber1, J K E Hegel.   

Abstract

Acne is a common skin disorder that can be problematic for adults as well as for adolescents. It has several key pathophysiological features such as follicular hyperkeratosis, elevated Propionibacterium acnes proliferation, and reactive inflammation, all of which should be targeted for an optimal outcome. Azelaic acid (AzA) has profound anti-inflammatory, antioxidative effects, and is bactericidal against a range of Gram-negative and Gram-positive microorganisms as well, including antibiotic-resistant bacterial strains. In addition, AzA's antikeratinizing effects are inhibitory toward comedones. AzA is effective overall in targeting multiple causes of acne and has been proven to be well tolerated in numerous clinical trials.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24280644     DOI: 10.1159/000354888

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  13 in total

1.  Identification and evaluation of anti-inflammatory properties of aqueous components extracted from sesame (Sesamum indicum) oil.

Authors:  Pragney Deme; Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-04-18       Impact factor: 3.205

2.  Gene expression profile of high-fat diet-fed C57BL/6J mice: in search of potential role of azelaic acid.

Authors:  Shanmugam Muthulakshmi; Alok K Chakrabarti; Sanjay Mukherjee
Journal:  J Physiol Biochem       Date:  2015-01-11       Impact factor: 4.158

3.  Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.

Authors:  Haibo Liu; Haiyan Yu; Jun Xia; Ling Liu; Guan J Liu; Hong Sang; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

Review 4.  Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.

Authors:  Martin Steinhoff; Marc Vocanson; Johannes J Voegel; Feriel Hacini-Rachinel; Gregor Schäfer
Journal:  Adv Ther       Date:  2016-07-18       Impact factor: 3.845

5.  Mature leaf concentrate of Sri Lankan wild type Carica papaya Linn. modulates nonfunctional and functional immune responses of rats.

Authors:  Chanika Dilumi Jayasinghe; Dinara S Gunasekera; Nuwan De Silva; Kithmini Kawya Mandakini Jayawardena; Preethi Vidya Udagama
Journal:  BMC Complement Altern Med       Date:  2017-04-26       Impact factor: 3.659

6.  Oral Administration of the Japanese Traditional Medicine Keishibukuryogan-ka-yokuinin Decreases Reactive Oxygen Metabolites in Rat Plasma: Identification of Chemical Constituents Contributing to Antioxidant Activity.

Authors:  Yosuke Matsubara; Takashi Matsumoto; Kyoji Sekiguchi; Junichi Koseki; Atsushi Kaneko; Takuji Yamaguchi; Yumiko Kurihara; Hiroyuki Kobayashi
Journal:  Molecules       Date:  2017-02-08       Impact factor: 4.411

Review 7.  Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Authors:  John W Frew; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2019-03-01       Impact factor: 5.091

8.  Efficacy and Safety of Azelaic Acid Nanocrystal-Loaded In Situ Hydrogel in the Treatment of Acne Vulgaris.

Authors:  Ivona Tomić; Sandra Miočić; Ivan Pepić; Dubravka Šimić; Jelena Filipović-Grčić
Journal:  Pharmaceutics       Date:  2021-04-16       Impact factor: 6.321

Review 9.  Optimizing Non-Antibiotic Treatments for Patients with Acne: A Review.

Authors:  Theresa N Canavan; Edward Chen; Boni E Elewski
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-19

10.  Azelaic Acid Induces Mitochondrial Biogenesis in Skeletal Muscle by Activation of Olfactory Receptor 544.

Authors:  Trung Thanh Thach; Chunyan Wu; Kwang Yeon Hwang; Sung-Joon Lee
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.